What to Watch. FDA order may sink Themis Medicare

Themis Medicare, maker of diclofenac 1 ml injection, has been directed by the Food and Drug Administration authorities to stop manufacturing a key product. The company has been given an opportunity to be heard; it is taking necessary steps to reply suitably. The product is being manufactured and marketed by the company; it is also being supplied to a pharma company on principal to principal basis. The company has filed a petition in the Delhi High Court.